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Discussion
Dr Vaughn A. Starnes (Los Angeles, Calif). Dr Alsoufi and col-
leagues have performed a retrospective analysis on 346 children
receiving aortic valves, either mechanical prostheses or the Ross
procedure, over a 21-year period. The operative experience was
from 1983 to 2004. In an attempt to neutralize confounding in
the selection of a prosthesis, a propensity-adjustment comparison
was performed. In summary, we have heard that the Ross procedure
confers survival advantage over the mechanical cohort because of
the higher operative mortality and the continuous attrition in the
late follow-up period in the mechanical group.
I agree with the conclusions of the article, and I also support the
use of the Ross procedure over the mechanical valve in children.
The reason mechanical valves fail in children include lack of
growth of the prosthesis, leading to a patient–prosthesis mismatch;
valve failure caused by pannus formation; poor compliance with
taking medications (warfarin), particularly in adolescents; and, in
women, the issue of pregnancy and warfarin. I have 3 questions.
Your analysis using a propensity-adjusted comparison was per-
formed to neutralize, as best you could, confounding variables that
overlap, but we have 1 curious nonoverlapping variable that I
would like to ask you about: the time of the study. From 1983 to
1990, you used mechanical valves alone, according to your article.
Would it not have been better to start this study from 1990 onward
when you had mechanical and Ross procedures available in your
facility? Could you explain why you chose the earlier time period?
Dr Alsoufi. Thank you, Dr Starnes. In a retrospective review of
outcomes in 2 diverse groups of patients, it might be difficult to per-
form a fair comparison. Propensity score analysis remains the best
analysis method that we can use in this situation. However, there
might have been several covariates that we have not identified or
used; those unmeasured covariates could have contributed to dispa-
rate outcomes in our patients.
Although the surgical era was different between the 2 groups of
patients, as you havementioned, it was not identified as a significant
factor for mortality in our risk analysis. We included patients before
1991 to increase the power of our study by adding more patients
and having longer follow-up. Moreover, surgical era was one of
the variables that we have used to create our propensity score.
Dr Starnes. Well, I have 2 interrelated questions, and I think it
pertains to looking at these 2 time periods. It appears from your ar-
ticle that a lot of mechanical valves were used early on, and then
you had a tendency in your facility to use Ross procedures later.
Therefore I have 2 questions based on that background.
Rheumatic heart disease comprised the largest cohort of patients
in your series and represented a risk factor for reoperation. Patients
with rheumatic heart disease who underwent a Ross procedure were
at even higher risk for reoperation. Do you currently recommend
a mechanical prosthesis in these children, or are you currently do-
ing Ross procedures?
Dr Alsoufi. Initially, after adopting the Ross procedure at our in-
stitution in 1991, it was offered to all patients. Later, our group was
one of the first to report an increased risk of failure after the Ross
procedure in patients with rheumatic valve disease. We have iden-
tified several risk factors for increased failure rate. Those included
patients who had active rheumatic fever at the time of AVR, pa-
tients who had pure aortic insufficiency and a dilated annulus larger
than 30 mm, and patients who had an aortic annulus 3 mm or more
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larger than that of the pulmonary valve. In those patients we do not
offer the Ross procedure anymore. In addition, we have adopted
some technical modifications, most importantly by trimming the
muscle rim underneath the autograft with sutures almost going to
the annulus level, because we had identified that this muscle often
dilated and contributed to late failure. Because we have changed
our selection criteria and adapted those modifications in 1999, we
have had 2 failures only in patients with rheumatic disease under-
going the Ross procedure. Although the follow-up is not very
long, this is an encouraging finding given that most of the failures
in the past were evident within the first 3 years after AVR.
Dr Starnes. For my final question, given the high operative
mortality in children receiving mechanical valves less than 5 years
of age, almost 50%, do you currently use the Ross procedure exclu-
sively in this age group?
Dr Alsoufi. Yes.
Dr Starnes. Again, I would like to thank you for providing me
the manuscript, which is excellently written, and thank the Associ-
ation for the privilege of the discussion.
Dr David J. Cohen (San Antonio, Tex). I had the privilege of
visiting your hospital while deployed during Operation Desert Storm,
and it was my impression at that time that many of your patients came
from many different countries and also from small villages, where
long-term follow-up for anticoagulation and for subacute bacterial en-
docarditis prophylaxiswould be impossible to follow. I amwondering
if much of the late attrition rate in your patients receiving mechanical
valves is related to this issue and whether this would be the same if
these patients had been treated, say, in the United States or in Europe?
Dr Alsoufi. The majority of our patients were from Saudi Ara-
bia, even though they came from all over the country. Although an-
ticoagulation follow-up is not done at our hospital but rather at local
centers, all those centers have anticoagulation clinics with well-es-
tablished anticoagulation protocols. The issue of compliance with
anticoagulation in children is definitely a major problem. Compli-
ance might be better in the Western world than in other developing
countries because of many social, educational, and logistic factors.
However, multiple other published series from Europe and the
United States showed similar findings, continuous attrition with
mechanical valves and high anticoagulation-related morbidity, in-
dicating that anticoagulation control in children remains a problem,
even in the Western world.
Dr Themistokles P. Chamogeorgakis (Athens, Greece). As far
as neonates, this is a difficult subgroup to manage. Do you have any
information or how many neonatal Ross procedures you did or
Ross–Konno combinations?
Dr Alsoufi. Our experience with the Ross procedure in infants is
limited to 10 patients only, with 1 (10%) death. Therefore despite our
large series, the number of infants and neonates is smaller than that
seen in other published reports. For the Ross–Konno procedure, we
have a large institutional experience, 39 patients with 2 (6%) deaths.
Dr James H. Oury (Rapid City, SD). I commend you on an ex-
cellent series, and it fills a gap, at least in the Ross registry data that
we have, including your data, of what happens to these children
long-term. Therefore my question is purely from a hemodynamic
status, and it is based on the fact that children, by their nature, ex-
ercise, sometimes wildly. To get some handle on this, we took
about 15 patients from our series and compared them. These
were athletes. We compared the athletes undergoing the Ross pro-
cedure with a group of so-called normal triathletes, and I can tell
you that at extreme exercise in young adults, the results are super-
imposable. Therefore my question to you is this: Given this unique
series, have you had the opportunity of comparing the patients un-
dergoing the Ross procedure with those receiving mechanical
valves in terms of their hemodynamic potential and looking at these
2 series as the kids grew older?
Dr Carlos J. Troconis (Caracas, Venezuela). From experiences
in undeveloped countries, where noncompliance on conventional
anticoagulation treatment is almost the rule and complications
from anticoagulation issues were frequently less likely to be found
in these population groups, other published series from Europe or
from the United States have advocated, in a prospective, non-
randomized, longitudinal multicenter trial, to test the hypothesis
that selected patients after AVR with an already established com-
mercial valve can be maintained safely with low-dose aspirin
only or with aspirin/clopidogrel.
Although we know that more patients and longer follow-up are
required to draw valid conclusions, I particularly think that this an-
ticoagulation modality, when applied to AVR, could be extended to
kids. Do you have any observations about that?
Dr Alsoufi. I will answer the last question first. All our patients
were anticoagulated with warfarin, with a recommended interna-
tional normalized ratio range between 2 and 3. Sometimes we added
aspirin for patients in whom maintaining international normalized
ratio within the therapeutic range was difficult, but we did not leave
them without anticoagulation. Although there are current trials to
maintain adult patients who have received a certain mechanical
valve while receiving clopidogrel and aspirin only, this is not yet
the standard of care, and that valve was not used in our patients.
To answer the first question, although the majority of our pa-
tients were asymptomatic, exercise data were largely unavailable.
We are currently collecting serial echocardiograms after AVR in
children with the purpose of examining trajectories for left ventric-
ular mass regression, recovery of ventricular dilatation, systolic
function, and progression of aortic annulus and root diameters,
and we hope to share this information with you in future meetings.
We do not have current plans to compare exercise performance be-
tween children who have undergone a Ross procedure versus those
who have received a mechanical valve. Although this has been pre-
viously done in adults, no data exist in children, and that will be an
excellent study to perform.
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